Carboline carboxamide compounds useful as kinase inhibitors

US8685969B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Chunjian Liu · Pennington, US
• James Lin · Lawrenceville, US
• George V. DeLucca · Wilmington, US
• Douglas G. Batt · Wilmington, US
• Qingjie Liu · Newtown, US

Key dates

• Filing date: Jun 16, 2011
• Grant date: Apr 1, 2014
• Expiry date: Jun 16, 2031

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, formula (I) are useful as kinase modulators, including Btk modulation.